$64.16
0.28 (+0.44%)
Johnson & Johnson (JNJ)
CAPS Rating:
Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.
Fool.com
The World's Greatest Investing Community
RSS Headlines
Fool UK
Recs
What can I say about JNJ that hasn't already been said? Well there's one thing. Like many smart investors with cash JNJ seems to be on a investment shopping spree. While others are panicking, JNJ is gobbling up pharma and other health care product companies, positioning itself for growth when the economy turns around.